Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
High-sensitivity Troponin in Cardiac Surgery
Author(s): Cuilin Zhu , Xiaomeng Wang , Xiao Liu , et al Added: 2 weeks ago

MI/ACS
Heart Disease in Pregnancy: Maternal and Neonatal Risk
Author(s): Rofila Dita Karmia , Mefri Yanni , Yusrawati , et al Added: 2 weeks ago

Electrophysiology & Arrhythmia

Heart Failure
Undetectable hs-TnI Serves as a De-risking Marker
Author(s): Phattararuethai Sabkaewyod , Prin Vathesatogkit , Piyamitr Sritara Added: 1 year ago

Prevention & Chronic Conditions
Efficacy and Safety of LAAO during Cardiac Surgery to Prevent Stroke
Author(s): Reynald Evan R Tugade , Billy Joseph David , Clara S Tolentino Added: 1 year ago

Electrophysiology & Arrhythmia

Prevention & Chronic Conditions
The Evolving Treatment Landscape for HFpEF in Cardiac Amyloidosis
Author(s): Added: 2 months ago
AHA Scientific Sessions 2025 - Dr Sarah Cuddy (Brigham and Women's Hospital, US) joins us to discuss the role of non-disease modifying treatments including SGLT2 inhibitors, mineralocorticoid receptor antagonists, GLP-1 receptor agonists, and implantable hemodynamic monitors in cardiac amyloidosis, and what this means for managing heart failure in this unique patient population.Interview… View more

Heart Failure
Cardiac Amyloidosis: Everywhere, but Nowhere
Author(s): Aqtab Mazhar Alias , Raja Ezman Raja Shariff , Norashikin Saidon , et al Added: 1 year ago

Heart Failure
Digital Healthcare in Cardiac Prevention Programme in Indonesia
Author(s): Bambang Dwiputra , Ade Meidian Ambari , Dwita Rian Desandri , et al Added: 1 year ago

Digital Health

Prevention & Chronic Conditions
ACC 25: Cardiac Biomarker Analysis from the EARLY TAVR Trial
Author(s): Brian Lindman Added: 9 months ago
ACC 2025 - Primary findings from EARLY-TAVR show the benefit of early TAVR intervention was consistent across biomarker subgroups.Dr Brian Lindman (Vanderbilt University Medical Center, Nashville, US) joins us onsite at ACC 2025 to discuss findings from the primary biomarker analysis from the EARLY TAVR trial (NCT03042104; Edwards Lifesciences). The analysis investigated cardiac biomarkers in… View more

Vascular Disease and Surgery
ESC 25 Hot Line Discussion: DIGIT-HF: Cardiac Glycosides in HFrEF
Author(s): Harriette Van Spall , Udo Bavendiek Added: 4 months ago
ESC Congress 2025 - Digitoxin reduced the risk of all-cause mortality and hospitalisation in patients with worsening heart failure.Dr Harriette Van Spall (McMaster University, CA) sits down with Prof Udo Bavendiek to explore the DIGIT-HF trial, investigating whether digitoxin can improve outcomes in patients with advanced chronic heart failure and reduced ejection fraction.This landmark study… View more

Heart Failure

Prevention & Chronic Conditions
Live Zoster Vaccination Linked to Reduced Cardiovascular Event Risk
Added: 5 months ago Source:  Radcliffe Cardiology
A large-scale, nationwide study from South Korea suggests that vaccination with the live zoster vaccine is associated with a significantly lower risk of various cardiovascular (CV) events in adults aged 50 and older. The findings indicate a protective association that persists for up to 8 years post-vaccination.¹This population-based cohort study analysed data from over 2.2 million individuals… View more

Demographic

Electrophysiology & Arrhythmia